Clinical Trial Update: Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stem cell transplantation in decompensated cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Tehran | Conditions: Cirrhosis | Phase 2 | Status: COMPLETED